Hasil Pencarian - Thuong V Nguyen

  • Menampilkan 1 - 4 hasil dari 4
Perbaiki Hasil
  1. 1
    Cholera returns to southern Vietnam in an outbreak associated with consuming unsafe water through iced tea: A matched case-control study.

    Cholera returns to southern Vietnam in an outbreak associated with consuming unsafe water through iced tea: A matched case-control study. oleh Thuong V Nguyen, Quang D Pham, Quoc K Do, Tai T Diep, Hung C Phan, Thang V Ho, Hong T Do, Lan T Phan, Huu N Tran

    Diterbitkan 2017-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Zika preparedness and response in Viet Nam

    Zika preparedness and response in Viet Nam oleh Dong T Nguyen, Hung T Do, Huy X Le, Nghia T Le, Mai Q Vien, Trieu B Nguyen, Lan T Phan, Thuong V Nguyen, Quang C Luong, Hung C Phan, Hai T Diep, Quang D Pham, Thinh V Nguyen, Loan KT Huynh, Dung CT Nguyen, Hang TT Pham, Khanh KH Ly, Huong NLT Tran, Phu D Tran, Tan Q Dang, Hung Pham, Long N Vu, Anthony Mounts, S Arunmozhi Balajee, Leisha D Nolen

    Diterbitkan 2018-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Estimating and mitigating the risk of COVID-19 epidemic rebound associated with reopening of international borders in Vietnam: a modelling study

    Estimating and mitigating the risk of COVID-19 epidemic rebound associated with reopening of international borders in Vietnam: a modelling study oleh Quang D Pham, MD, Robyn M Stuart, PhD, Thuong V Nguyen, MD, Quang C Luong, MD, Quang D Tran, PhD, Thai Q Pham, PhD, Lan T Phan, ProfPhD, Tan Q Dang, PhD, Duong N Tran, PhD, Hung T Do, PhD, Dina Mistry, PhD, Daniel J Klein, PhD, Romesh G Abeysuriya, PhD, Assaf P Oron, PhD, Cliff C Kerr, PhD

    Diterbitkan 2021-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Safety and immunogenicity of Nanocovax, a SARS-CoV-2 recombinant spike protein vaccine: Interim results of a double-blind, randomised controlled phase 1 and 2 trial

    Safety and immunogenicity of Nanocovax, a SARS-CoV-2 recombinant spike protein vaccine: Interim results of a double-blind, randomised controlled phase 1 and 2 trial oleh Thuy P. Nguyen, Quyet Do, Lan T. Phan, Duc V. Dinh, Hiep Khong, Luong V. Hoang, Thuong V. Nguyen, Hung N. Pham, Men V. Chu, Toan T. Nguyen, Quang D. Pham, Tri M. Le, Tuyen N.T. Trang, Thanh T. Dinh, Thuong V. Vo, Thao T. Vu, Quynh B.P. Nguyen, Vuong T. Phan, Luong V. Nguyen, Giang T. Nguyen, Phong M. Tran, Thuan D. Nghiem, Tien V. Tran, Tien G. Nguyen, Tuynh Q. Tran, Linh T. Nguyen, Anh T. Do, Dung D. Nguyen, Son A. Ho, Viet T. Nguyen, Dung T. Pham, Hieu B. Tran, Son T. Vu, Su X. Hoang, Trung M. Do, Xuan T. Nguyen, Giang Q. Le, Ton Tran, Thang M. Cao, Huy M. Dao, Thao T.T. Nguyen, Uyen Y Doan, Vy T.T. Le, Linh P. Tran, Ngoc M. Nguyen, Ngoc T. Nguyen, Hang T.T. Pham, Quan H. Nguyen, Hieu T. Nguyen, Hang L.K. Nguyen, Vinh T. Tran, Mai T.N. Tran, Truc T.T. Nguyen, Phat T. Ha, Hieu T. Huynh, Khanh D. Nguyen, Ung T. Thuan, Chung C. Doan, Si M. Do

    Diterbitkan 2022-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: